Gregory A. Odle - 15 Mar 2026 Form 4 Insider Report for ORTHOPEDIATRICS CORP (KIDS)

Reporting relationship: President of Scoliosis
Issuer ticker: KIDS
Reported as of: 15 Mar 2026
Net transaction value: -$145,469
SEC form: 4
Accepted by SEC: 17 Mar 2026, 16:18:05 UTC
Prior SEC filing: 18 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Daniel J. Gerritzen, Attorney-in-Fact

Key filing fact

Gregory A. Odle filed Form 4 for ORTHOPEDIATRICS CORP (KIDS) on 17 Mar 2026.

Key facts

This page summarizes Gregory A. Odle's Form 4 filing for ORTHOPEDIATRICS CORP (KIDS).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Mar 2026, 16:18.

Change

Previous filing in this sequence was filed on 18 Mar 2025.
Current net transaction value: -$145,469.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001719088 Primary reporting owner

Odle Gregory A

Relationship: President of Scoliosis
Address: C/O ORTHOPEDIATRICS CORP., 2850 FRONTIER DRIVE, WARSAW
Signature: /s/ Daniel J. Gerritzen, Attorney-in-Fact
Signature date: 17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KIDS transaction

Common Stock

Award

Transaction value
Shares: +47,380
Change %: +32%
Price: $0.000000^*
Shares after: 196,168
Date: 15 Mar 2026
Ownership: Direct

KIDS transaction

Common Stock

Sale

Transaction value: $145,469
Shares: -8,433
Change %: -4.3%
Price: $17.25
Shares after: 187,735
Date: 16 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.

Footnote F2

Includes restricted stock awards totaling 121,054 shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .